500 million dollars or RMB is not clear.
This paper summarizes 53 cases of medical device merger and acquisition in China from 20 13 to 20 14.
assignee
Investee
field
comment
Xinhua medical
Weishida medical treatment
Clinical detection
Huatuo International Development, a wholly-owned subsidiary of 20 13 12, plans to acquire 60% equity of Vesta Medical Co., Ltd. for 384.3 million yuan.
Xinhua medical
Remote jump machine
pharmaceutical equipment
2065438+In June 2003, 353 million acquired 90% equity of Shanghai Yuan Yue Pharmaceutical Machinery.
Dongfulong
Jianzhong medical treatment
Aseptic packaging and its materials
20 13, 1 1 40 million yuan participated in the private placement of Shanghai Jianzhong Medical Device Packaging Co., Ltd. and acquired part of the equity, with a shareholding ratio of not less than 20%.
Dongfulong
Shanghai Fan Dian
Biomedical materials
20165438+in 2003 10, the investment shall not exceed 35 million yuan, and some shares of Shanghai Fan Dian medical science and technology shall be acquired and increased, and the shareholding shall not be less than 5 1%.
Kailitai
Yisheng technology
Cardiovascular stent
In July of 20 13, 65,438+397 million acquired 29.73% equity of Yisheng Technology (Beijing), and it is planned to gradually acquire the remaining equity in 20 14 until it holds 100% equity.
Aidir
orthopedics
In 2065438+2003 10, 165438+2003, 80% equity of adil Medical Devices Co., Ltd. was acquired through additional issuance and cash, with a purchase consideration of 528 million yuan.
Mengfali
coulee
Massage products
20 13 1 1, 270 million acquired OGAWA, a company listed on the main board of Malaysia Stock Exchange.
Kexin biology
Zhongshan ruifu
blood taking needle
Paulette
Duotai medical treatment
Dialysis machine
Paulette
Hengxin biology
Hemodialysis concentrated solution, hemodialysis dry powder
20 13 In June, it acquired 0/00% equity of Liaoning Hengxin Bio/kloc-0 with over-raised funds of14.56 million yuan and increased its capital by120,000 yuan, totaling 26.56 million yuan.
Lepu medical treatment
Xinshuaike
Clopidogrel, etc.
2065438+June 2003, 390 million yuan acquired 60% equity of Henan Xinshuaike.
Renfu medicine
Beijing medical treatment
diagnosticum
Shang Rong medical treatment
Pude medical treatment
Sanitary materials
2065438+accumulated 90 million in August 2003. 50 million yuan was used to increase the capital of Pude Medical and acquire its 30.56% equity; 40 million yuan was used to acquire 24.44% equity of Pude Medical held by Pude Holdings.
Vanguard Wandong
Shanghai vanguard medical equipment
picture
Stryker
Chuangsheng holding
orthopedics
On 20 13 and 1 month, Stryker acquired 0/00% equity of Venture Capital for HK$ 5.9 billion, becoming the biggest M&A activity this year.
Chuangsheng holding
Chuangyiyi
surgical instrument
Hejia stock
Sichuan sixun
Medical informatization
20 13 in may, the subsidiary acquired 9 software copyright assets of Sichuan sixun, covering hospital management information system (HIS), clinical management information system (CIS) and regional medical and health service system (GMIS).
Jiashitang
Guangzhou Ji Jian
Instrument distribution
-
Platinum medical treatment
Medical equipment
David medical treatment
Yongxing medical treatment
infusion pump
20 1 165438+2003 10, it is planned to increase capital by 5 million yuan to acquire 0/00% equity of Ningbo Yongxing Medical Devices. After the transaction is completed, the registered capital of Yongxing Medical is 8 million yuan, and the company holds 0/00% equity of Yongxing Medical/KLOC.
Zhongyuan Huadian
Guangzhou Exxon
diagnosticum
20 14, 14 In June, Zhongyuan Huadian acquired 40% equity of Daqian Bio for 5.72 million yuan, becoming the largest shareholder.
2065438+On August 6th, 2004, the company conditionally increased its capital by 28.53 million yuan in three phases to become the controlling shareholder, holding 5 1% equity of Exxon.
Xilong chemical industry
New World-America
Tumor diagnostic reagent
2065438+2004 1 month, it is planned to acquire 75% equity of Fujian New World Biotechnology Co., Ltd. for 92.25 million yuan. More than 40 approvals, including 3 tumor markers.
Yonghe sunshine
diagnosticum
2065438+September 2004, Jiaxing Qingshi Xilong Equity Investment Fund, which accounts for 95. 14% of the company's investment, plans to increase its capital by 60.465 million yuan to Yonghe Sunshine (Hunan) Biotechnology Co., Ltd., and will hold 53 18% of the equity of Yonghe Sunshine after the capital increase.
Yabao pharmacy
Taiyige electronic
hearing-aid
20 14 In June, Beijing Yabao Investment, a wholly-owned subsidiary, plans to invest 35 million yuan to acquire 8.64% equity of Taiyige Electronics held by natural person Huang Zhaoming, and150,000 yuan will increase its capital by 3. 16%. Upon completion, * * * will hold 10.52%.
Sannuo biology
Huaguang upgrade
diagnosticum
2065438+In February 2004, Sannuo Bio 2.64 held no more than 20% of the shares of Huaguangsheng Technology and became the largest shareholder.
Fosun Pingyao
Currentmodelogic current-mode logic
Telemedicine
From 2065438 to February 2004, Fosun Industrial (Hong Kong), a wholly-owned subsidiary of Fosun Pharma, participated in the mutually beneficial privatization between the United States and China, acquired 30% equity of CML, and expanded medical services and medical devices business.
Qianshan Yao Ji
Hong Hao gene
genetic chip
On March 201April 3, Hunan Hong Hao Gene Biotechnology Co., Ltd. was acquired and increased its capital. This investment plan is 3,865,438 yuan+800,000 yuan.
Biology of Guan Hao
You Deqing
Development of artificial cornea
From 2065438 to March 2004, it is planned to invest 40 million yuan in Youdeqing by stages. After the investment is completed, Guan Hao Bio will account for 33.3% of the registered capital.
Hainan Haiyao
American bionic eye Company
biological materials
20 14 In March, Shanghai Lishengte Medical Technology Co., Ltd., a holding subsidiary, took a stake in bionic eye Company of the United States for no more than US$ 3 million and obtained its 16% equity.
Yuyue technology
Vanguard Wandong
Imaging equipment, surgical instruments, sanitary materials, etc.
201April acquired 5 1% equity of China Resources Wandong and 0/00% equity of Shanghai Medical Device Group.
Xinhua medical
Yingde company
Biopharmaceutical equipment
2065438+In April 2004, it is planned to acquire 85% equity of Yingde Company for 370 million yuan.
Paulette
Bo Tian Ao Sheng
haemodialysis
2065438+June 2004, Tianjin Boao Tiansheng Plastic Materials Co., Ltd. was increased with its own capital of/kloc-0.80 million yuan, accounting for 70% of the shares of the target company.
Peking University medicine
Comprehensive medical treatment
Tumor ablation
On June 8, 2014,020,000 yuan is planned to purchase 0/00% equity of Shenzhen Integrated Traditional Chinese and Western Medicine/KLOC-0, all of which will be paid by issuing shares.
Hanyu pharmacy
Biology of Ji Cheng
injector
On August 20th, 20 14, it is planned to acquire 100% equity of Gansu Ji Cheng Biopharmaceutical Co., Ltd. by issuing shares and paying cash, with the amount of1300 million.
Pu he Hua shun
Tianxinfu
endocranium
20 14 In August, Puhua Heshun Group (0 1358) acquired the entire equity of Beijing Tianxinfu Medical Company for 800 million yuan. Regenerated medical biomaterial artificial dura mater for neurosurgery, pioneer and leader in the industry.
Lepu medical treatment
Yalian best
diagnosticum
In August of 20 14, it is planned to invest in Beijing Yalian Black & Decker Technology and Trade Co., Ltd. with self-raised funds of 42011.82 million yuan, becoming the second largest shareholder.
1.25 billion invested in 7 1.39% equity of Beijing haihetian science and technology development co., ltd. ..
36.42 million yuan invested in Beijing Jin Wei Jie Technology Development (family medical and health comprehensive service platform), with 565,438+0% equity.
1400,000 yuan and Ningbo Meilintong Investment Management Center are jointly invested by the core management and technical team of the company to be established, holding 70% of the shares;
Liang Manchu
Bai Jing medical treatment
class monitor
2065438+In August 2004, Tianmu Pharmaceutical transferred 60% equity of Shenzhen Bai Jing Medical Devices Co., Ltd. to Liang Manman, the shareholder of the company, at a price of 7.29 million yuan.
Beilu pharmacy
Shihe gene
Gene sequencing
2065438+August 2004, it is planned to increase the capital of Nanjing Shihe Gene Biotechnology Co., Ltd. by 30 million yuan, accounting for 20% of the shares after the capital increase.
Chutian technology
Xinhua tong
Pharmaceutical water equipment
20 14 August, it is planned to purchase 0/00% equity of Xinhuatong/KLOC-0 by issuing shares and paying cash.
Changchun high-tech
Edwansi
Degradable metal coronary stent and orthopedic implant
2065438+August 2004, the allocated capital of 33.4407 million yuan increased by 44.5%.
Shang Rong medical treatment
Jinzhou area medical equipment
Orthopedic osseointegration implant
2065438+In September 2004, it is planned to acquire 66.2 1% equity of Zhangjiagang jinzhou area Medical Machinery Manufacturing Co., Ltd. with cash of RMB 0/0/0.4 million.
Huaping stock
Beijing kangruide
Medical quality inspection and digital information system
2065438+In September 2004, Beijing Kangruide increased its capital by 20 million yuan to acquire 40% equity.
Lidman
Desai diagnosis
diagnosticum
20 14 September, Lidman1800,000 investors bought Desai Diagnostic System (Shanghai) Co., Ltd. and part of its equity in Desai products. After the completion of this transaction, Lidman will hold 25% shares of Desai System and 365,438+0% shares of Desai Products.
Wei Wei; Carlyle fund
Haier special electrics
Medical equipment
2065438+September 2004, Carlyle Investment Group acquired 30% equity of Qingdao Haier Special Electric Appliance Co., Ltd. for 405 million yuan, Wei Wu Capital will hold 8% equity of special electric appliances, and Haier Venture Capital will hold 40% equity.
Jiashitang
Xinshunhe
Instrument distribution
2065438+September 2004, it is planned to acquire part of the equity of 23 companies including Sichuan Xinshunhe Trading Co., Ltd. for 250 million yuan. After the acquisition, it will account for 5 1% of the shares and become the largest shareholder and actual controller.
Lan Fan medical treatment
Liming medical treatment
haemodialysis
20 14, 10 In June, Fuzhou Dong Ze Medical Devices, a wholly-owned subsidiary of Lan Fan (Shanghai) Asset Management Co., Ltd., acquired 66.5% and 33.5% shares of Liming Medical for 8.645 million yuan and 4.355 million yuan respectively.
Answering all questions will build your authority image.